<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04882280</url>
  </required_header>
  <id_info>
    <org_study_id>Reverse DRC</org_study_id>
    <nct_id>NCT04882280</nct_id>
  </id_info>
  <brief_title>Dose-depedent Impact of Daytime Lighting on Evening Responses to Light</brief_title>
  <official_title>Dose-depedent Impact of Daytime Lighting on Evening Responses to Light</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Palo Alto Veterans Institute for Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Palo Alto Health Care System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to systematically examine the impact of different intensities of&#xD;
      daytime light and the subsequent impact that such exposure has on non-image forming responses&#xD;
      to light in the evening.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2022</start_date>
  <completion_date type="Anticipated">July 2024</completion_date>
  <primary_completion_date type="Anticipated">June 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Suppression of melatonin production</measure>
    <time_frame>4 hours</time_frame>
    <description>Difference in salivary melatonin concentrations between active arm and 3 lux control condition</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Phase shift in the timing of melatonin onset</measure>
    <time_frame>2 days</time_frame>
    <description>Change in the onset of melatonin secretion after experimental stimulus</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Sleep</condition>
  <arm_group>
    <arm_group_label>Low room</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low intensity (80 lux) room light</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal room</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal intensity (150 lux) room light</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bright room</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High intensity (500 lux) room light</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bright</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Very high intensity (1000 lux) room light</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Light</intervention_name>
    <description>10 hours of light exposure during the daytime, starting 2 hours after habitual wake time</description>
    <arm_group_label>Bright</arm_group_label>
    <arm_group_label>Bright room</arm_group_label>
    <arm_group_label>Low room</arm_group_label>
    <arm_group_label>Normal room</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Aged 18-35&#xD;
&#xD;
          2. Good health&#xD;
&#xD;
          3. Male or female&#xD;
&#xD;
          4. Normal color vision&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Sleep disorders&#xD;
&#xD;
          2. Extreme chronotypes&#xD;
&#xD;
          3. Routine smoker&#xD;
&#xD;
          4. Significant hearing loss&#xD;
&#xD;
          5. Depressed&#xD;
&#xD;
          6. Alcohol use disorder&#xD;
&#xD;
          7. Use of illegal drugs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jamie Zeitzer, PhD</last_name>
    <phone>6504935000</phone>
    <email>jzeitzer@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 7, 2021</study_first_submitted>
  <study_first_submitted_qc>May 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2021</study_first_posted>
  <last_update_submitted>May 10, 2021</last_update_submitted>
  <last_update_submitted_qc>May 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VA Palo Alto Health Care System</investigator_affiliation>
    <investigator_full_name>Jamie M. Zeitzer, Ph.D.</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

